Literature DB >> 16186286

Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study.

Yasufumi Doi1, Yutaka Kiyohara, Michiaki Kubo, Toshiharu Ninomiya, Yoshiyuki Wakugawa, Koji Yonemoto, Masanori Iwase, Mitsuo Iida.   

Abstract

OBJECTIVE: We examined the association between high-sensitivity C-reactive protein (CRP) levels and the development of diabetes in a general Japanese population. RESEARCH DESIGN AND METHODS: A total of 1,759 Japanese subjects, aged 40-79 years and without diabetes (according to American Diabetes Association fasting criteria), were stratified into three groups according to CRP tertiles by sex and followed up prospectively for a mean of 9.0 years.
RESULTS: During the follow-up, 131 subjects (67 men and 64 women) developed diabetes. In both sexes, the age-adjusted cumulative incidence of diabetes increased significantly as the tertiles of CRP levels increased. In multivariate analyses, the risk of developing diabetes was significantly higher in the highest CRP tertile than in the lowest after adjustment for a number of confounding factors (odds ratio 2.63 [95% CI 1.23-5.65] for men and 2.25 [1.01-5.01] for women). In stratified analyses, this CRP-diabetes association was stronger in subjects without obesity or other risk factors related to insulin resistance and in nondrinking subjects.
CONCLUSIONS: Our findings suggest that elevated CRP concentration is a significant predictor of diabetes in the general Japanese population, independent of obesity and insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186286     DOI: 10.2337/diacare.28.10.2497

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  50 in total

1.  Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes.

Authors:  Jukka Montonen; Dagmar Drogan; Hans-Georg Joost; Heiner Boeing; Andreas Fritsche; Erwin Schleicher; Matthias B Schulze; Tobias Pischon
Journal:  Eur J Epidemiol       Date:  2010-12-28       Impact factor: 8.082

Review 2.  The use of high-sensitivity assays for C-reactive protein in clinical practice.

Authors:  Kiran Musunuru; Brian G Kral; Roger S Blumenthal; Valentin Fuster; Catherine Y Campbell; Ty J Gluckman; Richard A Lange; Eric J Topol; James T Willerson; Milind Y Desai; Michael H Davidson; Samia Mora
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08-19

3.  Lifestyle modifications and the resolution of obstructive sleep apnea syndrome: a case report.

Authors:  Thaddeus R Gala; David R Seaman
Journal:  J Chiropr Med       Date:  2011-04-05

4.  Abdominal Aortic Diameter and the Risk for Asymptomatic Peripheral Arterial Disease in Patients with Type 2 Diabetes.

Authors:  Moatasem Salah Amer; Omar Hussien Omar; Randa Abdel Wahab Reda; Tomader Taha Abdel Rahman; Doha Rasheedy
Journal:  Int J Angiol       Date:  2015-06

5.  Association between C-reactive protein and type 2 diabetes in a Tunisian population.

Authors:  Hanen Belfki; Samir Ben Ali; Souha Bougatef; Decy Ben Ahmed; Najet Haddad; Awatef Jmal; Monia Abdennebi; Habiba Ben Romdhane
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

6.  Serum C-reactive protein level and prediabetes in two Asian populations.

Authors:  C Sabanayagam; A Shankar; S C Lim; J Lee; E S Tai; T Y Wong
Journal:  Diabetologia       Date:  2011-01-26       Impact factor: 10.122

7.  Serological evidence of infections and Type 2 diabetes: the MultiEthnic Study of Atherosclerosis.

Authors:  P L Lutsey; J S Pankow; A G Bertoni; M Szklo; A R Folsom
Journal:  Diabet Med       Date:  2009-02       Impact factor: 4.359

8.  C-reactive protein and gamma-glutamyltransferase concentrations in relation to the prevalence of type 2 diabetes diagnosed by glucose or HbA1c criteria in Chinese adults in Qingdao, China.

Authors:  J Ren; Z C Pang; W G Gao; H R Nan; S J Wang; L Zhang; Q Qiao
Journal:  Exp Diabetes Res       Date:  2010-11-07

9.  Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure.

Authors:  Tiina Ahonen; Juha Saltevo; Markku Laakso; Hannu Kautiainen; Esko Kumpusalo; Mauno Vanhala
Journal:  Mediators Inflamm       Date:  2009-08-20       Impact factor: 4.711

10.  Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Alain G Bertoni; Gregory L Burke; James A Owusu; Mercedes R Carnethon; Dhananjay Vaidya; R Graham Barr; Nancy S Jenny; Pamela Ouyang; Jerome I Rotter
Journal:  Diabetes Care       Date:  2010-01-22       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.